BioData World Congress 2017
BioData World Congress 2017
BioData World Congress 2017 will bring together academia, industry and healthcare to discuss and debate how to come together to improve efficiencies within bio IT and biodata to the benefit of patients worldwide.
About the conference
The two day conference will feature case study applications of Big Data and Genomics to drive precision medicine into the clinic through the assembly of the multidisciplinary cohort. The event will cover a range of different topics including:
- How to manage data generated in bioinformatics;
- How to utilise NGS to develop more targeted therapeutics;
- How to practically apply genomic data in precision medicine;
- Utilizing the Cloud for collaborative research \ Developing secure information systems;
- Ethical considerations in the sharing of genomic data;
- How to transition big data into the clinic;
- How to access open source technologies in LS research;
- How to apply big data analytics to mine information.
- Explore the best services and products in the market;
- Network with other industry leaders to do business and share knowledge as the industry moves forward;
- Build new contacts and strengthen your existing relationships;
- Be part of the innovation and showcase your offerings in the Innovation Zone;
- Share your work and achievements with your industry peers in the Poster Zone.
- Networking drinks reception at the close of day one will allow you to unwind with your peers and continue conversations in good company;
- Our extended lunch periods will provide ample time to network between sessions and allow for more opportunities for casual conversations and introductions;
- Moderted roundtable discussions on key topics.
Rolf Apweiler is Director of EMBL-EBI, together with Ewan Birney. Prior to this position he was Joint Associate Director, after many years of leading protein resources such as UniProt. Rolf has made a major contribution to methods for the automatic annotation of proteins, making it possible to add relevant information to proteome sets for entire organisms. He has spearheaded the development of standards for proteomics data, and his teams have maintained major collections of protein identifications from proteomics experiments (PRIDE) and molecular interactions (IntAct). He also led EMBL-EBI’s contribution to the Gene Ontology and is the current Director of Open Targets.
Rolf received his PhD from the University of Heidelberg in 1994, and has been at EMBL since 1987. His major contribution to the field of proteomics was recognised by the the Human Proteomics Organisation’s “Distinguished Achievement Award in Proteomics” in 2004 and his election to President of the Human Proteomics Organisation, which he held in 2007 and 2008. In 2012, he was elected as a member of EMBO and in 2015 he was elected to an ISCB (International Society for Computational Biology) fellow. Rolf also served over many years on a multitude of Editorial Boards and Scientific Advisory Boards.